Pharmaceutical care via telemedicine for patients with Chronic Obstructive Pulmonary disease or Asthma

Pharmaceutical care for patients with Chronic Obstructive Pulmonary disease or Asthma

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

REBEC

Registry ID

RBR-8n3xjfs

Enrollment

Registered

2026-04-22

Start date

2025-10-01

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

This is a non-randomized, non-controlled, single-arm clinical study with a before-and-after intervention design, involving individuals with Chronic Obstructive Pulmonary Disease (COPD) or asthma recei

Eligibility

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Individuals over 18 years of age with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) or asthma, regardless of the presence of comorbidities, were included

Exclusion criteria

Exclusion criteria: Patients under 18 years of age or those with cognitive difficulties that interfere with understanding the questions were excluded

Design outcomes

Primary

Measure	Time frame
The effectiveness of pharmaceutical care via telepharmacy is expected to be observed through a reduction of at least 20% in the occurrence of medication-related problems or an increase of at least 20% in adherence to medication treatment in patients with Chronic Obstructive Pulmonary Disease or asthma, comparing the periods before and after implementation of the intervention	—

Secondary

Measure	Time frame
No secondary outcomes are expected	—

Countries

Contacts

Public ContactMaria de Lima

Universidade Federal de Alfenas

maria.aduclecia@sou.unifal-mg.edu.br+55(81) 99686-8407

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: May 1, 2026